Abbott | ABT - Capital De Empréstimo

Preço das Ações
91.37
Mudança Diária
-2.49 -2.65%
Mensal
-10.32%
Anual
-30.12%
Q2 Previsão
89.18




Capital De Empréstimo Alterar Data
Abbott USD 29.64B 19.74B 2026-03
Agilent USD 3.05B 0 2025-12
AtriCure USD 61.86M 0 2025-12
Baxter International USD 9.47B 726M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Bio-Rad Laboratories USD 1.2B 300K 2025-12
Boston Scientific USD 11.01B 19M 2025-12
Cooper Companies USD 1.88B 578.5M 2025-12
Danaher USD 17.56B 855M 2026-03
Dexcom USD 1.24B 53.6M 2025-12
Edwards Lifesciences USD 600M 1.7M 2026-03
Globus Medical USD 436K 9K 2025-12
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 37.53B 1.91B 2026-03
Masimo USD 518M 41.1M 2025-12
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 734.04M 1.12M 2025-12
Pfizer USD 57.41B 93M 2025-09
Smith & Nephew USD 3.3B 22M 2025-12
Solventum Corp USD 5.04B 102M 2025-12
Stryker USD 14.86B 14M 2025-12
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teleflex USD 2.54B 30.06M 2025-12
Terumo JPY 99.9B 12M 2025-12
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Zimmer Biomet Holdings USD 6.3B 636.9M 2026-03